Intuitive Surgical (ISRG) Projected to Post Earnings on Tuesday

Intuitive Surgical (NASDAQ:ISRG) is anticipated to post its quarterly earnings results after the market closes on Tuesday, January 28th. Analysts expect Intuitive Surgical to post earnings of $1.76 per share and revenue of $2,201,260.00 billion for the quarter. Investors that wish to register for the company’s conference call can do so using this link.

Intuitive Surgical Trading Up 1.5 %

Shares of NASDAQ:ISRG opened at $592.64 on Tuesday. The stock has a market capitalization of $211.09 billion, a P/E ratio of 95.28, a price-to-earnings-growth ratio of 4.66 and a beta of 1.39. The stock’s 50-day moving average price is $540.66 and its 200-day moving average price is $499.64. Intuitive Surgical has a 12-month low of $362.14 and a 12-month high of $597.68.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of the company’s stock in a transaction dated Tuesday, October 29th. The shares were sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at $2,788,899.12. The trade was a 3.30 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The shares were sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the sale, the insider now directly owns 8,757 shares in the company, valued at $4,597,425. This trade represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 43,509 shares of company stock valued at $22,602,212 over the last quarter. Corporate insiders own 0.80% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of a number of analyst reports. Royal Bank of Canada lifted their price target on Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research note on Friday, October 18th. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. increased their price target on shares of Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Leerink Partners upped their price objective on shares of Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Finally, Stifel Nicolaus increased their target price on shares of Intuitive Surgical from $525.00 to $610.00 and gave the stock a “buy” rating in a report on Thursday, December 5th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.